Your shopping cart is currently empty

EK1 is a peptide-based coronavirus (CoV) fusion inhibitor that exhibits broad-spectrum inhibitory activity against various coronaviruses. EK1 demonstrates significantly enhanced pan-coronavirus fusion inhibitory activity and effectively suppresses SARS-CoV-2. It can form a stable six-helix bundle (6HB) structure with short α-hCoV and long β-hCoV N-terminal heptad repeat sequences.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | EK1 is a peptide-based coronavirus (CoV) fusion inhibitor that exhibits broad-spectrum inhibitory activity against various coronaviruses. EK1 demonstrates significantly enhanced pan-coronavirus fusion inhibitory activity and effectively suppresses SARS-CoV-2. It can form a stable six-helix bundle (6HB) structure with short α-hCoV and long β-hCoV N-terminal heptad repeat sequences. |
| Sequence | Ser-Leu-Asp-Gln-Ile-Asn-Val-Thr-Phe-Leu-Asp-Leu-Glu-Tyr-Glu-Met-Lys-Lys-Leu-Glu-Glu-Ala-Ile-Lys-Lys-Leu-Glu-Glu-Ser-Tyr-Ile-Asp-Leu-Lys-Glu-Leu |
| Sequence Short | SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.